Anavex Life Sciences
AVXL
#7822
Rank
โ‚น29.84 B
Marketcap
โ‚น334.04
Share price
1.63%
Change (1 day)
-64.83%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -โ‚น4.03 Billion

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚น4.62 Billion a decrease over its 2023 earnings that were of -โ‚น4.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น4.03 Billion-12.74%
2024 -โ‚น4.62 Billion14.77%
2023 -โ‚น4.03 Billion-17.49%
2022 -โ‚น4.88 Billion22.96%
2021 -โ‚น3.97 Billion35.36%
2020 -โ‚น2.93 Billion12.65%
2019 -โ‚น2.61 Billion29.09%
2018 -โ‚น2.02 Billion36.33%
2017 -โ‚น1.48 Billion17.11%
2016 -โ‚น1.27 Billion20.91%
2015 -โ‚น1.05 Billion-6.29%
2014 -โ‚น1.12 Billion337.28%
2013 -โ‚น0.26 Billion
2008 -โ‚น0.48 Billion106.01%
2007 -โ‚น0.23 Billion8848.98%
2006 -โ‚น2.56 Million-79.99%
2005 -โ‚น12.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚น5.98 B-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น0.6 Billion-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚น5.87 B-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น0.43 Billion-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA